Tradestie Institutional Equity Comparison Engine

RBOT.WS vs EW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EW Overall Edge

EW Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EW at 30.1x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EW
RBOT.WS N/M vs EW 30.1x Fwd P/E
Growth & Margin Winner EW
Op Margin N/A vs 28.8% ยท YoY N/A vs +10.5%
Momentum & Technical Winner EW
1Y -67.2% vs +18.4% ยท 52W Pos 0% vs 82%
Options & Structure Winner EW
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$101.85
-1.95% 1D
Market Cap $59.7B
1M Return +13.05%
1Y Return +18.4%
Forward P/E 30.1x
Unified AI Score
40.0 / 100 SELL
Tech 24.0 Fund 43.0 Flow 55.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RBOT.WS -67.2% EW +18.4% Spread: +66.45 pp (EW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RBOT.WS TTM Op. Margin: N/A EW TTM Op. Margin: 28.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs EW. Trailing 12-month operating profitability (RBOT.WS N/A vs EW 28.8%) and valuation multiples (RBOT.WS N/M vs EW 30.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RBOT.WS (1) vs EW (9)
Institutional Metric RBOT.WS EW Criterion Row Winner
Market Capitalization Scale N/A $59.7B Larger Scale EW
Trailing P/E Ratio Valuation N/M 60.4x Lower Multiple EW
Forward P/E Ratio Valuation N/M 30.1x Lower Multiple EW
Revenue Growth (YoY) Growth N/A +10.5% Higher Growth EW
Operating Margin (TTM) Profitability N/A 28.8% Higher Margin EW
Net Profit Margin Profitability N/A 15.3% Higher Margin EW
Return on Equity (ROE) Capital Efficiency N/A 9.3% Higher ROE EW
52-Week Range Position Momentum 0% ($0โ€“$0) 82% ($75โ€“$108) Stronger Trend EW
Beta / 30D Volatility Risk Regime N/A 0.43ฮฒ ยท 27% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 50.1 / 100 (HOLD) 40.0 / 100 (SELL) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RBOT.WS vs EW Buy Guide
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RBOT.WS nor EW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.